Non-ownership Filings
| GSK to lower drug prices and expand access in US | Dec. 22, 2025 |
| Exdensur (depemokimab ulla) approved by US FDA | Dec. 17, 2025 |
| Nucala receives positive CHMP opinion for COPD | Dec. 12, 2025 |
| Depemokimab receives positive CHMP opinion | Dec. 12, 2025 |
| Positive CHMP opinion on Arexvy for all adults 18+ | Dec. 12, 2025 |
| Blujepa approved in US for gonorrhoea indication | Dec. 11, 2025 |
| Block Listing Application | Dec. 11, 2025 |
Ownership Update Filings
| Director/PDMR Shareholding | Dec. 22, 2025 |
| Transaction in Own Shares | Dec. 22, 2025 |
| Transaction in Own Shares | Dec. 19, 2025 |
| Transaction in Own Shares | Dec. 18, 2025 |
| Transaction in Own Shares | Dec. 17, 2025 |
| Transaction in Own Shares | Dec. 16, 2025 |
| Transaction in Own Shares | Dec. 15, 2025 |